ATE128351T1 - Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen. - Google Patents

Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.

Info

Publication number
ATE128351T1
ATE128351T1 AT92910661T AT92910661T ATE128351T1 AT E128351 T1 ATE128351 T1 AT E128351T1 AT 92910661 T AT92910661 T AT 92910661T AT 92910661 T AT92910661 T AT 92910661T AT E128351 T1 ATE128351 T1 AT E128351T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
digestive tract
treating digestive
tract pain
edible pharmaceutical
Prior art date
Application number
AT92910661T
Other languages
English (en)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE128351T1 publication Critical patent/ATE128351T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
AT92910661T 1991-04-04 1992-03-13 Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen. ATE128351T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04

Publications (1)

Publication Number Publication Date
ATE128351T1 true ATE128351T1 (de) 1995-10-15

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92910661T ATE128351T1 (de) 1991-04-04 1992-03-13 Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.

Country Status (16)

Country Link
EP (1) EP0578768B1 (de)
JP (1) JPH06506682A (de)
KR (1) KR100238565B1 (de)
AT (1) ATE128351T1 (de)
AU (1) AU665349B2 (de)
BR (1) BR9205827A (de)
CA (1) CA2106215C (de)
CZ (1) CZ282105B6 (de)
DE (1) DE69205158T2 (de)
DK (1) DK0578768T3 (de)
ES (1) ES2077417T3 (de)
GR (1) GR3017580T3 (de)
HU (1) HU213203B (de)
RU (1) RU2126249C1 (de)
SK (1) SK121293A3 (de)
WO (1) WO1992017164A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662840A1 (de) * 1992-10-09 1995-07-19 The Procter & Gamble Company Pharmazeutische Zusammensetzung und Methode zur Behandlung von Schnupfen
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
WO1994025009A1 (en) * 1993-04-30 1994-11-10 The Procter & Gamble Company Coated pharmaceutical compositions
CA2163003C (en) * 1993-05-19 2003-01-28 Akira Nakagawa Solubilizer and external preparations containing the same
CA2169735A1 (en) * 1993-08-17 1995-02-23 Henry C. Caldwell Oral compositions of h2-antagonists
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
JPH09504293A (ja) * 1993-10-28 1997-04-28 ザ、プロクター、エンド、ギャンブル、カンパニー マグネシウムアルミニウムシリケート及び複数の活性成分を含有した速溶解性剤形
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
CA2184361C (en) * 1994-03-24 2000-12-05 Francis Bernard Chapura Solid dose forms containing bismuth
WO1996002262A2 (en) * 1994-07-20 1996-02-01 American Home Products Corporation Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル

Also Published As

Publication number Publication date
JPH06506682A (ja) 1994-07-28
DE69205158D1 (de) 1995-11-02
BR9205827A (pt) 1994-06-28
EP0578768B1 (de) 1995-09-27
CA2106215C (en) 1997-05-27
CZ226093A3 (en) 1994-04-13
AU1761492A (en) 1992-11-02
CZ282105B6 (cs) 1997-05-14
AU665349B2 (en) 1996-01-04
EP0578768A1 (de) 1994-01-19
KR100238565B1 (ko) 2000-02-01
HU213203B (en) 1997-03-28
RU2126249C1 (ru) 1999-02-20
HU9302970D0 (en) 1994-01-28
DE69205158T2 (de) 1996-04-18
HUT65881A (en) 1994-07-28
DK0578768T3 (da) 1996-02-05
CA2106215A1 (en) 1992-10-05
ES2077417T3 (es) 1995-11-16
GR3017580T3 (en) 1995-12-31
WO1992017164A1 (en) 1992-10-15
SK121293A3 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
DE69205158D1 (de) Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
DE69213010D1 (de) Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
IS4397A (is) Ný lyfjablanda til meðhöndlunar á verkjum sem inniheldur staðdeyfiefni, skautuð lípíð og tríasýlglýseról
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE231719T1 (de) Neue pharmazeutische formulierungen
SE8801732D0 (sv) Ny komposition
NO923643D0 (no) Legemiddel for behandling av gastrointestinale forstyrrelser
DK0470117T3 (da) Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
Berglund et al. Sports medicine update.
DK344489D0 (da) Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
ATE195868T1 (de) Pharmazeutische zusammensetzungen von gallium- komplexen von 3-hydroxy-4-pyronen
ATE94388T1 (de) Verwendung von otiloniumbromid fuer die topische anwendung im gastrointestinaltrakt und entsprechende geeignete pharmazeutische formulierung.
RU97117568A (ru) Гастропульмин
Meurer et al. Information from your family doctor: What should I know about Helicobacter pylori infections?
RU93019936A (ru) Состав, оказывающий тонизирующее действие на организм человека и теплокровных животных
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
UA31739A (uk) Спосіб лікування деструктивних процесів шлункa та дванадцятипалої кишки
IT8821437A0 (it) Procedimento per prolungare la permanenza nel tratto gastrointestinale di farmaci in formulazioni ad effetto prolungato e forme di dosaggio cosi' ottenute.
TH13515EX (th) สารที่ใช้เป็นยาสำหรับรักษาอาการอักเสบหรือบรรเทาอาการปวด
RU98105696A (ru) Средство для лечения и профилактики болезней полости рта
TH44437A (th) การใช้ประโยชน์ของอัลลิลลามีน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee